Related Experiment Video
Updated: Jan 5, 2026
Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
Published on: October 17, 2025
The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism
Daniel John Araujo1, Karensa Tjoa1, Kaoru Saijo1,2
1Department of Molecular & Cell Biology, University of California, Berkeley, Berkeley, CA, United States.
Abstract:
Microglia are the resident, innate immune cells of the central nervous system (CNS) and are critical in managing CNS injuries and infections. Microglia also maintain CNS homeostasis by influencing neuronal development, viability, and function. However, aberrant microglial activity and phenotypes are associated with CNS pathology, including autism spectrum disorder (ASD). Thus, improving our knowledge of microglial regulation could provide insights into the maintenance of CNS homeostasis as well as the prevention and treatment of ASD. Control of microglial activity is in part overseen by small, lipid-derived molecules known as endogenous cannabinoids (endocannabinoids). Endocannabinoids are one component of the endocannabinoid system (ECS), which also includes the enzymes that metabolize these ligands, in addition to cannabinoid receptor 1 (CB1) and 2 (CB2). Interestingly, increased ECS signaling leads to an anti-inflammatory, neuroprotective phenotype in microglia. Here, we review the literature and propose that ECS signaling represents a largely untapped area for understanding microglial biology and its relationship to ASD, with special attention paid to issues surrounding the use of recreational cannabis (marijuana). We also discuss major questions within the field and suggest directions for future research.
Insights
The endocannabinoid system (ECS) regulates microglia, the brain's immune cells. Targeting ECS signaling may offer new strategies for treating neurodevelopmental disorders like autism spectrum disorder (ASD).
Area of Science:
- Neuroscience
- Immunology
- Neurodevelopmental Disorders
Background:
- Microglia are key innate immune cells in the central nervous system (CNS), essential for homeostasis and responding to injury.
- Dysregulated microglial activity is linked to CNS pathologies, including autism spectrum disorder (ASD).
- Endocannabinoids (ECS) are lipid molecules that modulate microglial function.
Purpose of the Study:
- To review the role of the endocannabinoid system (ECS) in regulating microglial activity.
- To explore the potential of ECS modulation for maintaining CNS homeostasis.
- To investigate the relationship between ECS signaling, microglial function, and autism spectrum disorder (ASD).
Main Methods:
- Literature review of studies on microglia, ECS, and ASD.
- Analysis of the impact of ECS signaling on microglial phenotypes.
- Discussion of current knowledge gaps and future research directions.
Main Results:
- Increased ECS signaling promotes an anti-inflammatory and neuroprotective microglial phenotype.
- The ECS represents a promising, yet under-explored, target for understanding microglial biology.
- Cannabis use and its effects on the ECS and microglia warrant further investigation in the context of ASD.
Conclusions:
- The ECS plays a critical role in microglial regulation and CNS homeostasis.
- Modulating the ECS offers potential therapeutic avenues for ASD and other CNS disorders.
- Further research is needed to elucidate the complex interactions within the ECS, microglia, and neurodevelopmental conditions.
More Related Videos
06:12Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
Published on: September 6, 2024
07:41Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
Published on: February 3, 2016
